Sinus Node Dysfunction
20
1
2
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
5.0%
1 terminated out of 20 trials
92.9%
+6.4% vs benchmark
10%
2 trials in Phase 3/4
54%
7 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (20)
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up
BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S
Predicting Severe Cardiac Arrhythmias in the Perioperative Period Using AI-ECG
The Fluoroless-CSP Trial Using Electroanatomic Mapping
Allometric-Pace Study
LBBAP Data Collection Registry
Suture Closure AFtEr VEIN Access for Cardiac Procedures (SAFE-VEIN) Trial
Physiologic Pacing Registry
Permanent Pacemaker Implantation or Cardioneuroablation in Sinus Node Dysfunction
Left Bundle Area Versus Selective His Bundle Pacing
Cardioneuroablation Versus Pacemaker Implantation for the Treatment of Symptomatic Sinus Node Dysfunction
Registry to Improve the Adoption of Consensus Treatment Guidelines (IMPROVE Brady)
Safety and Performance Study of the INGEVITY Lead
ImageReady(TM) MR Conditional Pacing System Clinical Study
Effectiveness of Closed Loop Stimulation (CLS) With His Bundle Lead Placement
Atrial Fibrillation With Sinus Node Dysfunction: Intensive Device Follow-up
A Comparison of Rate Response Performance in Pacemaker Patients With an Indication of Sinus Node Dysfunction
Evolution of the PR Interval in Patients Implanted With a Pacemaker Using the SafeR Mode
Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease
Spontaneous Atrio Ventricular Conduction Preservation